76 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Anticoagulants" (76 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Reversal of the Antithrombotic Action of New Oral Anticoagulants
Conditions: Thrombosis;   Anticoagulant-induced Bleeding;   Anticoagulant Overdosage;   Hemorrhage
Interventions: Drug: Rivaroxaban;   Drug: Dabigatran
2 Not yet recruiting Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
Conditions: Anticoagulants;   Thromboembolism;   Hemorrhage
Interventions: Other: Measurement of Plasma Concentrations of NOACs;   Genetic: Identification of ABCB1 polymorphisms coding for P-gp
3 Not yet recruiting Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events
Conditions: Incidence of Readmissions;   ADE's Due to Anticoagulants
Intervention:
4 Recruiting Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve.
Conditions: Aortic Valve Disease;   Heart Valve Prosthesis Implantation;   Anticoagulants
Intervention: Drug: Rivaroxaban
5 Unknown  Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin
Conditions: Deep Vein Thrombosis;   Enoxaparin;   Anticoagulants
Intervention: Drug: Enoxaparin
6 Recruiting Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Conditions: Venous Thromboembolism;   Atrial Fibrillation
Intervention: Other: complications and compliance with GIHP recommendations
7 Recruiting Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
Conditions: Ischemic Stroke;   Patent Foramen Ovale;   Atrial Septal Aneurysm;   Migraine
Interventions: Drug: aspirin;   Drug: Antivitamins K;   Device: Devices for PFO closure
8 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
9 Recruiting Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant
Condition: Venous Thromboembolism
Intervention:
10 Unknown  Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Condition: Coronary Artery Disease
Interventions: Drug: clopidogrel + aspirin;   Drug: heparin + clopidogrel + aspirin;   Drug: enoxaparin + clopidogrel + aspirin;   Drug: bivalirudin + clopidogrel + aspirin
11 Recruiting Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education
Condition: Cardiac Surgery
Interventions: Behavioral: VKA (antivitamin K) education;   Behavioral: conventional hospital education
12 Recruiting Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism
Condition: Venous Thromboembolism
Intervention:
13 Recruiting Register for New Oral Anticoagulants
Condition: Anticoagulation Treatment
Intervention:
14 Recruiting Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Condition: No High Risk of Hemorrhage
Intervention: Device: Intermittent pneumatic compression of the lower limbs
15 Recruiting Sequential Expansion of Comparative Effectiveness of Anticoagulants
Condition: Atrial Fibrillation
Intervention:
16 Not yet recruiting A Clinical Study of Lyophilized Plasma in Patients on Warfarin
Condition: Anticoagulant Therapy
Interventions: Biological: Lyophilized Plasma;   Biological: Licensed Plasma
17 Recruiting Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
Intervention:
18 Unknown  Determination of Residual Anticoagulatory Effects of Fondaparinux
Condition: Anticoagulant Prophylaxis/Therapy
Intervention:
19 Recruiting Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention:
20 Unknown  Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent
Condition: Healthy
Intervention: Drug: Indobufen

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years